Antiviral effect of arginine against herpes simplex virus type 1

International Journal of Molecular Medicine

Volumn 23, Issue 4, 2009, Pages 495-499

  Naito, Takeshi ^a   Irie, Hiroshi ^b   Tsujimoto, Kazuko ^c   Ikeda, Keiko ^c   Arakawa, Tsutomu ^d   Koyama, A Hajime ^c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d ALLIANCE PROTEIN LABORATORIES   (United States)

Author keywords

Antiviral; Arginine; Herpes simplex virus; Influenza virus; Vesicular stomatitis virus

Indexed keywords

ARGININE; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; DRUG DNA INTERACTION; GROWTH CURVE; GROWTH INHIBITION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROGENY; REACTION TIME; RNA REPLICATION; VIROGENESIS; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; ARGININE; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 1, HUMAN; HUMANS; TIME FACTORS; VERO CELLS; VIRUS REPLICATION;

EID: 67649443807     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000156     Document Type: Article

References (17)

1. Cowan MM: Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582, 1999.
2. Isaacs CE, Wen GY, Xu W, Jia JH, Rohan L, Corbo C, Di Maggio V, Jenkins EC Jr and Hiller S: Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob Agents Chemother 52: 962-970, 2008.
3. Katsuyama Y, Yamasaki H, Tsujimoto K, Koyama AH, Ejima D and Arakawa T: Butyroyl-arginine as a potent virus inactivation agent. Int J Pharm 361: 92-98, 2008.
4. Yamasaki H, Tsujimoto K, Koyama AH, Ejima D and Arakawa T: Arginine facilitates inactivation of enveloped viruses. J Pharm Sci 97: 3067-3073, 2008.
5. Utsunomiya H, Ichinose M, Uozaki M, Tsujimoto K, Yamasaki H and Koyama AH: Antiviral activities of coffee extracts in vitro. Food Chem Toxicol 46: 1919-1924, 2008.
6. Brorson K, Krejci S, Lee K, Hamilton E, Stein K and Xu Y: Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol Bioeng 82: 321-329, 2003.
7. Koyama AH and Uchida T: The effect of ammonium chloride on the multiplication of herpes simplex virus type 1 in Vero cells. Virus Res 13: 271-282, 1989.
8. Koyama AH: Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res 37: 285-290, 1995.
9. Koyama AH, Irie H, Ueno F, Ogawa M, Nomoto A and Adachi A: Suppression of apoptotic and necrotic cell death by poliovirus. J Gen Virol 82: 2965-2972, 2001.
10. Kurokawa M, Koyama AH, Yasuoka S and Adachi A: Influenza virus overcomes apoptosis by rapid multiplication. Int J Mol Med 3: 527-530, 1999.
11. Koyama AH and Miwa Y: Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J Virol 71: 2567-2571, 1997.
12. Koyama AH and Uchida T: Quantitative studies on the maturation process of herpes simplex virus type 1 in Vero cells. Virus Res 10: 281-286, 1988.
13. Koyama AH, Arakawa T and Adachi A: Acceleration of virusinduced apoptosis by tumor necrosis factor. FEBS Lett 426: 179-182, 1998.
14. Koyama AH, Fukumori T, Fujita T, Irie H and Adachi A: Physiological significance of apoptosis in animal virus infection. Microbes Infect 2: 1111-1117, 2000.
15. Takada H, Kishimoto C, Hiraoka Y and Ochiai H: Oral Larginine prevents murine coxsackievirus B3 myocarditis. Int J Cardiol 86: 272-279, 2002.
16. Agawa H, Ikuta K, Minamiyama Y, Inoue M and Sairenji T: Down-regulation of spontaneous Epstein-Barr virus reactivation in the P3HR-1 cell line by L-arginine. Virology 304: 114-124, 2002.
17. Wu JJ, Pang KR, Huang DB and Tyring SK: Advances in antiviral therapy. Dermatol Clin 23: 313-322, 2005.